The integration of BNP and NT-proBNP into clinical medicine

The integration of BNP and NT-proBNP into clinical medicine

Bibliographic Details
Main Author:	Swiss Medical Weekly
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2007-01-01
Series:	Swiss Medical Weekly
Subjects:	heart failure Btype natriuretic peptide Dyspnoea
Online Access:	https://www.smw.ch/index.php/smw/article/view/686

Similar Items

Correlation of NT-proBNP levels with clinical and echocardiographic features in evaluation of patients admitted with heart failure
by: Dhinakaran K, et al.
Published: (2023-12-01)

Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room?
by: Tuba Cimilli Ozturk, et al.
Published: (2011-01-01)

Serum brain natriuretic peptide (BNP) and N-terminal brain natriuretic peptide (NT-proBNP) in heart valve disease
by: J.A. Moolman, et al.
Published: (2017-04-01)

NT-proBNP and Echocardiographic Parameters in Patients with Acute Heart Failure
by: Radek Pudil, et al.
Published: (2007-01-01)

B-type natriuretic peptide (BNP): can it improve our management of patients with congestive heart failure?
by: Swiss Medical Weekly
Published: (2002-11-01)

Correlates of Plasma NT‐proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial
by: Leonard Chiu, et al.
Published: (2024-04-01)

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
by: Claire Sweeney, et al.
Published: (2021-12-01)

Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction
by: Melissa A. Daubert, et al.
Published: (2021-05-01)

Original paper<br>Weight reduction decreases NT-proBNP levels in obsese coronary patients with chronic diastolic heart failure
by: Giuseppe Cocco, et al.
Published: (2007-06-01)

ANALYSIS OF CHANGE IN NT-proBNP AFTER ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY IN PATIENT WITH HEART FAILURE
by: Intan Kusuma Dewi, et al.
Published: (2017-08-01)

NT‐proBNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure
by: Isaac R. Whitman, et al.
Published: (2019-04-01)

Prognostic Value of NT-proBNP versus Killip Classification in Patients with Acute Coronary Syndromes
by: Thiago M. B. Souza, et al.

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials
by: Stefanie M. Werhahn, et al.
Published: (2022-02-01)

ANALYSIS OF CHANGES IN THE SERUM LEVEL NT-proBNP AFTER ACE INHIBITORS THERAPY IN PATIENTS WITH HEART FAILURE
by: Halla Hisan Hartoto, et al.
Published: (2017-08-01)

Obesity and Serial NT‐proBNP Levels in Guided Medical Therapy for Heart Failure With Reduced Ejection Fraction: Insights From the GUIDE‐IT Trial
by: Vibhu Parcha, et al.
Published: (2021-04-01)

Joint Associations of Obesity and NT‐proBNP With the Incidence of Atrial Fibrillation in the ARIC Study
by: Zakaria Almuwaqqat, et al.
Published: (2019-10-01)

Clinical predictors of all‐cause mortality in patients presenting to specialist heart failure clinic with raised NT‐proBNP and no heart failure
by: Pankaj Garg, et al.
Published: (2020-08-01)

Associations between diet quality and NT-proBNP in U.S. adults, NHANES 1999-2004
by: Ping Yang, et al.
Published: (2023-12-01)

The Prognostic Role of Global Longitudinal Strain and NT-proBNP in Heart Failure Patients Receiving Cardiac Resynchronization Therapy
by: Nikolaos P. E. Kadoglou, et al.
Published: (2024-02-01)

ASA Status, <i>NPPA/NPPB</i> Haplotype and Coronary Artery Disease Have an Impact on BNP/NT-proBNP Plasma Levels
by: Markus Hahn, et al.
Published: (2022-02-01)

Point-of-care NT-proBNP monitoring for heart failure: observational feasibility study in primary care
by: Jason Chami, et al.
Published: (2022-09-01)

NT-proBNP: A Biochemical Marker of Maternal Complications in Pre-eclampsia
by: Supriya Kumari, et al.
Published: (2017-11-01)

Utility of NT-proBNP as an objective marker of postoperative heart failure after coronary artery bypass surgery: a prospective observational study
by: Huiqi Jiang, et al.
Published: (2021-07-01)

Change in the NT‐proBNP/Mature BNP Molar Ratio Precedes Worsening Renal Function in Patients With Acute Heart Failure: A Novel Predictor Candidate for Cardiorenal Syndrome
by: Hiroyuki Takahama, et al.
Published: (2019-09-01)

Fasting Plasma Ketone Bodies Are Associated with NT-proBNP: A Potential Mechanism to Provide Fuel for the Failing Heart
by: Constantin L. Palm, et al.
Published: (2024-03-01)

The impact of glutamate infusion on postoperative NT-proBNP in patients undergoing coronary artery bypass surgery: a randomized study
by: Huiqi Jiang, et al.
Published: (2020-05-01)

Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines
by: Mladosievicova Beata, et al.
Published: (2012-10-01)

Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
by: Lidia Staszewsky, et al.
Published: (2021-11-01)

The Potential Role of Salivary NT-proBNP in Heart Failure
by: Aidonis Rammos, et al.
Published: (2023-08-01)

Effects of Breed, Exercise, and a Two-Month Training Period on NT-proBNP-Levels in Athletic Dogs
by: Frane Ivasovic, et al.
Published: (2022-12-01)

Can NT-proBNP Levels Be an Early Biomarker of Reduced Left Ventricular Ejection Fraction in Preterm Infants?
by: Ya-Lan Lin, et al.
Published: (2022-07-01)

Função diastólica na estenose aórtica: correlação com NT-ProBNP e remodelamento pós-operatório Correlation to NT-ProBNP and remodeling after cardiac surgery
by: Berta Paula Napchan Boer, et al.
Published: (2013-05-01)

Serum level of apelin-13 negatively correlated with NT-proBNP in heart failure patients
by: Goidescu Cerasela Mihaela, et al.
Published: (2016-12-01)

Usefulness of NT-proBNP in the follow-up of patients after myocardial infarction
by: Radosavljević-Radovanović Mina, et al.
Published: (2016-01-01)

The role of ProBNP in differentiation of cardiogenic and non-cardiogenic syncope: A diagnostic accuracy study
by: Afshin Amini, et al.
Published: (2022-07-01)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
by: Brian Kerr, et al.
Published: (2022-12-01)

NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study
by: Justin B. Echouffo‐Tcheugui, et al.
Published: (2023-06-01)

NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: The getABI-study
by: Henrik Rudolf, et al.
Published: (2020-08-01)

Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP
by: Annette Masuch, et al.
Published: (2018-08-01)

Importance of the ‘area under the curve’ from serial NT‐proBNP measurements during treatment with sacubitril/valsartan
by: Reza Mohebi, et al.
Published: (2023-10-01)